Company: CGC
Filing Date: 2025-02-07
Form Type: 10-Q
Source: 0000950170-25-015839
Chunk: 156

Company: Canopy Growth Corp
Filing Date: 2025-02-07
Form: 10-Q
Item: Item 2
Chunk 156
---
32
    %

    36
    %

    -

    (400) bps

    Net loss from continuing operations
     
    $
    (121,896
    )
     
    $
    (230,276
    )
     
    $
    108,380

    47
    %

    Net loss from continuing operations   attributable to Canopy Growth Corporation
     
    $
    (121,896
    )
     
    $
    (230,276
    )
     
    $
    108,380

    47
    %

    Basic and diluted loss per share from   continuing operations1
     
    $
    (1.11
    )
     
    $
    (2.78
    )
     
    $
    1.67

    60
    %

    1 For the three months ended December 31, 2024, the weighted average number of outstanding common shares, basic and diluted, totaled 110,306,430 (three months ended December 31, 2023 - 82,919,190).

Revenue

We report net revenue in four segments: (i) Canada cannabis; (ii) international markets cannabis; (iii) Storz & Bickel; and (iv) This Works. Revenue derived from the remainder of our operations are included within "other". The following table presents segmented net revenue for the three months ended December 31, 2024 and 2023:

    Net Revenue
     
    Three months ended December 31,

    (in thousands of Canadian dollars)
     
    2024

    2023

    $ Change

    % Change

    Canada cannabis

    Canadian adult-use cannabis1
     
    $
    21,153

    $
    23,490

    $
    (2,337
    )

    (10
    %)

    Canadian medical cannabis2

    19,575

    16,894

    2,681

    16
    %

    $
    40,728

    $
    40,384

    $
    344

    1
    %

    International markets cannabis3
     
    $
    12,024

    $
    10,527

    $
    1,497

    14
    %

    Storz & Bickel
     
    $
    22,009